Las Condes

40 / 164

170
REFERENCIAS BIBLIOGRáFICAS
1. Standars of American Diabetes Association. Classification and
Diagnosis of Diabetes. Diabetes Care 2015; 38: S8-S16.
2. Chakera A, Steele A, Gloyn A, Shepherd M, Ellard S, Hattersley A.
Recognition and management of individuals with hyperglycemia
because of a heterozygous glucokinase mutation. Diabetes Care
2015; 38: 1383-1392.
3. Pearson E, Velho G, Clark P, et al. Beta-cell genes and diabetes:
quantitative and qualitative differences in the pathophysiology
of hepatic nuclear factor-1alpha and glucokinase mutations.
Diabetes 2001; 50 (Suppl 1): S101–S107.
4. Shields B, McDonald T, Ellard S, Campbell M, Hyde C, Hattersley A
The development and validation of a clinical prediction model to
determine the probability of MODY in patients with young-onset
diabetes. Diabetologia 2012; 55: 1265–1272.
5.
calculator.
6. Rubio-Cabezas O, Klupa T, Malecki M. Permanent neonatal
diabetes mellitus-the importance of diabetes differential
diagnosis in neonates and infants. Eur J Clin Invest 2011; 4:
323–333.
7. Flanagan S, Patch A, Mackay D et al. Mutations in ATP-sensitive
K-channel genes cause transient neonatal diabetes and
permanent diabetes in childhood or adulthood Diabetes 2007;
56: 1930–1937.
8. Alcolado J. Laji K, Gill-Randall R. Maternal transmission of
diabetes. Diabet Med 2002; 19 : 89-98.
9. Diker-Cohen T, Cochran E, Gorden P, Brown R. Partial and
generalized lipodystrophy: comparison of baseline characteristics
and response to metreleptin. J Clin Endocrin Metab 2015; 100:
1802-1810.
10. Morrison M. Pancreatic cancer and diabetes. Adv Exp Med Biol
2012; 771: 229-239.
11. Oda K, Moran A. New insights into cystic fibrosis-related diabetes
in children. Lancet Diabetes Endocrinol 2013; 1: 152-158.
12. Clinical Care Guidelines for Cystic Fibrosis–Related Diabetes: A
position statement of the American Diabetes Association and
a clinical practice guideline of the Cystic Fibrosis Foundation,
endorsed by the Pediatric Endocrine Society. Diabetes Care 2010;
33: 2697-2708.
13. Powell L, Yapp T. Hemochromatosis. Clin Liver Dis 2000; 4: 211-
228.
14. Resmini E, Minuto F, Colao A, Ferone D. Secondary diabetes
associated with principal endocrinopathies: the impact of new
treatment modalities. Acta Diabetol 2009; 46 : 85-95.
15. Petersons C, Mangelsdorf B, Jenkins A et al. Effects of low-dose
prednisolone on hepatic and peripheral insulin sensitivity, insulin
secretion and abdominal adiposity in patients with inflammatory
rheumatologic disease. Diabetes Care 2013; 36: 2822-2829.
16. Correll C, Detraux J, De Lepeleire J, De Hert A. Effects of
antipsychotics, antidepressants and mood stabilizers on risk for
physical diseases in people with schizophrenia, depression and
bipolar disorder. World Psychiatry 2015; 14: 119–136.
17. De Wit S, Sabin CA, Weber R et al. Incidence and risk factors for
new-onset diabetes in HIV-infected patients the data collection
on adverse events of anti-HIV drugs (D:A:D) Study. Diabetes Care
2008; 31: 1224–1229.
18. Sattar N, Preiss D, Murray HM et al Statins and risk of incident
diabetes: a collaborative meta-analysis of randomized statin
trials. Lancet 2010; 375: 735–742.
19. Preiss D, Seshasai SR, Welsh P et al. Risk of incident diabetes with
intensive-dose compared with moderate-dose statin therapy: a
meta-analysis. JAMA 2011: 305: 2556–2564.
20. Ridker P, Pradhan , MacFadyen J, Libby P, Glynn R Cardiovascular
benefits and diabetes risks of statin therapy inprimary prevention:
an analysis from the JUPITER trial. Lancet 2012; 380: 565–571.
21. Meigs J, CupplesL, Wilson P. Parental transmission of type 2
diabetes: the Framingham Offspring Study. Diabetes 2000; 49:
2201-2207.
22. Sapru A, Gitelman SE, Bhatia S et al Prevalence and characteristics
of type 2 diabetes mellitus in 9-18 year-old children with diabetic
ketoacidosis. J Pediatr Endocrinol Metab. 2005; 18: 865-872.
23. Chernausek SD, Arslanian S, Caprio S et al. Relationship Between
Parental Diabetes and Presentation of Metabolic and Glycemic
Function in Youth With Type 2 Diabetes: Baseline Findings From
the TODAY Trial. Diabetes Care 2015. doi:10.2337/dc15-1557.
24. Mayer-Davis E, Davis C, Saadine J et al. SEARCH for Diabetes
in Youth Study Group. Diabetic retinopathy in the SEARCH for
Diabetes in Youth Cohort: a pilot study. Diabetes Med 2012; 29:
1148-1152.
25. Rapid rise in hypertension and nephropathy in youth with type 2
diabetes. The TODAY clinical trial. Diabetes Care 2013; 36: 1735–
1741.
26. Dart A, Sellers E, Martens P et al. High burden of kidney disease
in youth-onset type 2 diabetes. Diabetes Care 2012; 35: 1265–
1271.
27. Umpierrez G, Smiley D, Kitabchi A. Narrative Review: Ketosis-Prone
Type 2 Diabetes Mellitus. Ann Intern Med 2006; 144: 350-357.
28. Concha L, Durruty P, García de los Ríos M. Diabetes Mellitus tipo 2
con tendencia a la cetosis. Caso clínico. Rev Med Chile 2015; 143:
1215-1218.
29. Fourlanos S, Dotta F, Greenbaum C et al. Latent autoimmune
diabetes in adults (LADA) should be less latent. Diabetologia
2005; 48: 2206–2212.
30. Pollak F, Vásquez T. Diabetes autoinmune (latente) del adulto. Rev
Med Chile 2012; 140: 1476-1481.
31. Zhou Z, Xiang Y, Ji L, Jia W, Ning G, Huang G et al. Frequency,
Immunogenetics, and clinical characteristics of Latent
Autoimmune Diabetes in China. Diabetes 2013; 62: 543–550
32. Sharif A, Hecking M, de Vries A et al. Proceedings From an
International Consensus Meeting on Post transplantation
Diabetes Mellitus: Recommendations and Future Directions. Am
J of Transplant 2014; 14: 1992–2000.
33. Sharif A, Cohney S. Post-transplantation diabetes—state of the
art. Published
online November 25, 2015
8587(15)00387-3.
[REV. MED. CLIN. CONDES - 2016; 27(2)160-170]